Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001209191-21-069423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-14 | 2021-12-10 | DYN | COO | A - Grant | $0.00 | +40.3K | 73.8K | +121% | $0 | |
| D | 2021-12-14 | 2021-12-10 | DYN | COO | A - Grant | $0.00 | +60.5K | 60.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | A | A | 40,315 | $0.00 | 73,768 | D | — | — | (F1) Consists of shares of Common Stock issuable under 40,315 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 10, 2022. (F2) Includes 67,243 unvested RSUs. Each unvested RSU represents the right to receive one share of Common Stock upon vesting. |
| 2 | Derivative | Stock Option (right to buy) | 2021-12-10 | A | A | 60,472 | $0.00 | 60,472 | D | $13.12 · — to 2031-12-09 | 60,472 Common Stock | (F3) This option was granted on December 10, 2021. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 10, 2025. |